Vaccine Resources

The United Kingdom (UK) has a comprehensive national immunisation programme which comprises both routine and selective immunisation schedules (UK Health Security Agency [UKHSA], 2023). The routine programme includes those vaccines offered to the population, with eligibility predicated on age. For the last few years, vaccine coverage has been
falling in the majority of children’s and young people’s immunisation programmes (UKHSA, 2022; UKHSA 2023a; UKHSA 2023b; UKHSA 2023c). The decline in coverage has been made worse by the Covid-19 pandemic and consequent lockdowns, illness among recipients, and confusion and hesitancy about vaccines in general. This article discusses the drop in coverage of the adolescent immunisation programmes in England, and the role that general practice nurses (GPNs) and primary care immunisers can play in ensuring that young people are offered missing vaccines. The benefit of this catch-up activity is seen in reduced risk of morbidity and mortality from vaccine preventable illness in both individuals
and those around them.

Delivering the flu vaccination programme this coming season will be a greater challenge than ever before. The impact of COVID-19 on all healthcare services will also be felt when trying to deliver a vaccination programme in a short period of time to numerous patients, and perhaps an even greater number of patients than in previous years. There are various options in terms of delivery models and plans, but it is important that those who give the majority of vaccines in general practice, general practice nurses (GPNs), are involved in the planning of a delivery model which best suits the practice and the practice population. Careful risk assessment and documentation of decisions is important, as well as the ability to be flexible during the season and ready to offer flu vaccine to other eligible groups as the season progresses.

Shingles is a painful and debilitating disease which disproportionately affects older adults. Despite an effective vaccine, the use of which has reduced cases of shingles and the subsequent complication of postherpetic neuralgia, many eligible older adults are not receiving the vaccine. Uptake is lower than would be hoped for and has declined each year since the programme was introduced in 2013. This year, efforts are being made to reinvigorate interest in the vaccination programme and to provide supporting literature and information. General practice nurses (GPNs) are instrumental in advising patients about vaccination and will deliver the majority of vaccines. This article provides an overview of the disease, its cause, the role of immunity, risk and incidence, disease course, treatment, prevention and how to improve uptake by employing best practice initiatives. GPNs can use this information to advocate shingle vaccination and improve uptake and protection for the vulnerable older adults in the population.